2016 revenue outlook of $618 - 635M is very respectable. Everything looks on track except the stock price.
Consolidation in the diagnostics space will provide a floor value to CPHD at $30, with a take-out as high as $50.
JPM downgrade. Very discouraging when the schills throw in the towel after a 90% plunge
Only in New York my friends, only in New York
Let's not forget that small cap biotech has been decimated over the past month with many selling below cash values. Every Tom #$%$ and Harry hedge fund punter owned the likes of Bluebird and others. They had to sell to meet margin calls and redemptions from investors who were told the smart money knew better. Sorry Oscar...
More like a small gas leak PSSSSSSSSSSSSSSSSSSSSSSSS. Timberrrrrr is more akin to a very large cap company collapsing.
HSIC is a world class dental and medical distributor who only takes on products it knows it can move...
Idiots are your best friend, they make it possible to make money in a zero sum game - like the stooge at the poker table!